Anticholinergics for Cervical Edema in Labor

Recruiting now · Phase 2/Phase 3

Conditions studied: Labor Dystocia

In brief

The purpose of this study is to is to determine the clinical effectiveness of a single dose of intravenous (IV) medication for the prevention of labor arrest and cesarean delivery in primiparous women undergoing trial of labor.

Key facts

Study ID

NCT06702670

Run by

The University of Texas Health Science Center, Houston

People needed

200

Starts

2025-03-25

Expected to finish

2027-04-09

Last updated by the study team

2026-05-06

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Primiparous
• Viable single intrauterine pregnancy
• ≥ 34 weeks of gestation
• Ruptured membranes
• Category I tracing at time of inclusion
• Active phase of labor (>=6 cm of cervix dilation)

You may not qualify if…

• Category II or III tracing
• Allergy to the study medication (IV Diphenhydramine)

Where it is running

• The University of Texas Health Science Center at Houston — Houston, Texas, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.